NCT02101463 Terminated. Reason given: Principal Investigator left the organization and took the IDE/Study with him clinicaltrials.gov/show/NCT021

NCT02177773 Terminated. Reason given: FDA approved agent for this indication during enrollment clinicaltrials.gov/show/NCT021

NCT02187822 Terminated. Reason given: lack of funding by company providing TPI-287 clinicaltrials.gov/show/NCT021

NCT03290092 Terminated. Reason given: In accordance with the protocol, following the occurrence of two SUSARs, the TOTEM trial was stopped early for safety reasons. clinicaltrials.gov/show/NCT032

NCT03479034 Withdrawn. Reason given: Investigator decided not to proceed in Australia at this stage. clinicaltrials.gov/show/NCT034

NCT02730715 Suspended. Reason given: Re-evaluation of amount of T Cell collection needed. clinicaltrials.gov/show/NCT027

NCT02314598 Terminated. Reason given: No chance to meet the foreseen target of patients with study endpoint clinicaltrials.gov/show/NCT023

NCT02735551 Terminated. Reason given: Inadequate participant enrollment during recruitment period. clinicaltrials.gov/show/NCT027

NCT02716896 Terminated. Reason given: Study ended due to lack of eligible subjects and funding not renewing clinicaltrials.gov/show/NCT027

NCT02497612 Terminated. Reason given: All treatment arms met the futility criteria for efficacy during the pre-planned interim analysis, therefore the study was stopped. clinicaltrials.gov/show/NCT024

NCT03250689 Terminated. Reason given: Study terminated due to a change in the benefit-risk profile for danirixin in COPD. clinicaltrials.gov/show/NCT032

Show more
botsin.space

A Mastodon instance for bots and bot allies.